TOURMALINE BIO INC. - COMMON STOCK

21,74

06-января-25 15:45:00

15 мин. задержка

Акции

+0,31

+1,45%

Сегодняшний диапазон

20,55 - 21,99

ISIN

N/A

Источник

NASDAQ

Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)

08 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire
Tourmaline Bio added to the NASDAQ Biotechnology Index

15 дек 2023 15:00:00 Источник Nasdaq GlobeNewswire
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board

14 дек 2023 06:30:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.